T
here is compelling evidence that the gastrointestinal commensal microbiota is instrumental in shaping the functions of the immune system. 1 The short-chain fatty acids (SCFAs), mainly acetate, propionate and butyrate, which are the end products of dietary fibers after bacterial metabolism, act as an interface between the microbiota and immune cells. 2 In a recent article in Nature Immunology, Mariño et al. 3 reported that the levels of acetate and butyrate in the blood and feces of nonobese diabetic (NOD) mice, a mouse model of human type 1 diabetes (T1D), are inversely correlated with the disease. The NOD mice were completely protected from the development of diabetes by the administration of a combination of the acetate-and butyrate-yielding diets. Such SCFAs inhibited pathogenic effector T cells and induced CD4 + Foxp3 + regulatory T cells (Tregs), thereby contributing to the unprecedented therapeutic effect. 3 The findings of this study may open a new avenue to prevent and treat patients with T1D with medicinal food or nutraceuticals rather than conventional pharmaceutics.
In T1D, insulin-producing β-cells in the pancreas are destroyed by pathogenic immune cells. Although the exact mechanisms triggering the onset of T1D remain to be fully understood, current evidence indicates that both genetic and environmental factors are implicated. 4 There is also evidence to indicate that microRNAs regulate the immunopathology of diabetes. 5 Recent studies support the notion that dietary factors and gut microbiota, as well as their interplay with the immune system, play a crucial role in the development of T1D. 6, 7 As shown by Mariño et al., 3 SCFAs, including acetate and butyrate, act as the link between the diet, gut microbiota and immune cells in the development of T1D. In agreement with this observation, another study of NOD mice also found that susceptibility to diabetes was correlated with reduced fecal levels of SCFAs. 8 SCFAs largely represent the healthpromoting beneficial effect of gut microbiota and fiber in diets based on their interactions with metabolite-sensing G protein-coupled receptors (GPCRs), which are expressed in the gut epithelium and immune cells. 9, 10 The generation, trafficking and function of Tregs, which are key participants in the maintenance of homeostasis of both the immune system and microbiota in the gut, are regulated by SCFAs. 11 As shown in a previous study, the beneficial effects of SCFAs on the autoimmune inflammatory responses can be achieved by simply using a dietary approach. 12 Although it is conceivable that SCFAs have a beneficial effect in the inhibition of the development of diabetes, the mechanisms of this effect remain elusive. In the current study, multiple mechanisms have been revealed by a series of carefully designed experiments. 3 To examine the underlying mechanisms of the effect of specific SCFAs, NOD mice were fed an acetate-yielding or a butyrate-yielding diet. A similar strategy was previously employed to study the effect of dietary factors on the development of disease in NOD mice, which led to the finding that a gluten-free diet largely prevents diabetes, whereas a cereal-based diet promotes the development of diabetes. 13 Mariño et al. found that the consumption of an acetylate-or butyrate-yielding diet alone protected islets from infiltration by immune cells in NOD mice and thereby reduced the incidence of diabetes. Notably, the diet containing an optimal dose of both acetate and butyrate completely protected the mice from development of the disease. By contrast, a propionateyielding diet did not show such a function. 3 Pathogenic anti-islet T cells have a prominent role in the destruction of β-cells and in the development of diabetes. 14 This study found that an acetate-and butyrate-yielding diet inhibited the expansion of autoreactive T cells and consequently decreased their number and frequency in the spleen and pancreatic lymph nodes (PLNs). This effect was mediated by the inhibition of the capacity of B cells to present antigen and co-stimulate T-cell activation.
Tregs are known to protect against T1D. 15 It was previously reported that all SCFAs, for example, acetate, propionate and butyrate, have the capacity to promote the de novo differentiation of Tregs (induced Tregs (iTregs)), and expand pre-existing naturally occurring Tregs (nTregs) 11 or enhance the immunosuppressive function of Tregs. In this study, Mariño and colleagues showed that the ingestion of both acetate-and butyrateyielding diets resulted in the expansion of Tregs in the colon and spleen but not in the PLNs and mesenteric lymph nodes (MLNs). To determine whether the increased number of Tregs was because of the induction of de novo differentiation (for example, iTregs) or the expansion of nTregs, highly purified Foxp3/gfp − T cells from NOD.Foxp3-GFP transgenic mice were transferred into NOD.SCID mice, followed by the treatment with an acetate-or a butyrateyielding diet. The results indicated that butyrate promoted the conversion of naive T cells into iTregs, whereas acetate had no such capacity. An acetate-yielding diet treatment is likely to stimulate the proliferation of nTregs, since it markedly increased the number of Tregs in NOD mice. The exact mechanism of this effect of an acetate-yielding diet should be further investigated. Although this study did not show the effect of a diet yielding both acetate and butyrate on the number of Tregs, it is reasonable to speculate that the number of Tregs should be markedly higher than that in mice treated with an acetate-yielding diet or butyrate-yielding diet alone. Furthermore, this study revealed that dietary butyrate markedly increased the abundance of acetylated histone H3K9 and pentacetylated histone H4 at the Foxp3 promoter in splenic T cells, which is indicative of an enhanced suppressive function of Tregs. Therefore, acetate and butyrate preferentially inhibited pathogenic T cells and promoted Treg functions, respectively. Presumably, the complementary activities of these two SCFAs are the basis for the maximal inhibition of diabetes in NOD mice by a diet yielding both acetate and butyrate.
According to this study, the inhibitory effect of acetate on the proliferative expansion of pathogenic T cells in NOD mice was caused by an impaired capacity of the antigenic presentation and co-stimulation functions of B cells. Butyrate also inhibited the expression of CD86 and proliferation of B cells in vitro and reduced the expression of CD86 in IL-12-producing mature marginal-zone B cells in vivo. However, the butyrateyielding diet by itself only moderately reduced autoreactive T cells in NOD mice and had no effect on autoreactive T cells in NOD8.3 mice. It is known that Tregs have the capacity to directly inhibit B cells in the mouse model of autoimmune disease, 16 in addition to their wellknown effect of inhibiting T cells. Although the butyrate-yielding diet markedly increased the number and function of Tregs in NOD mice, both autoreactive T cells and B cells were not significantly suppressed in the same NOD mice that were fed a butyrateyielding diet, compared with mice treated with an acetate-yielding diet. It is understandable that these seemingly contrasting results are caused by the complicated nature of autoimmune disorders and the responses of different immune cells. However, it also suggests the potential role of other immunomodulatory mechanisms. Indeed, Mariño and colleagues also found that other factors, such Figure 1 Complete inhibition of diabetes in non-obese diabetic (NOD) mice through combined acetate and butyrate ingestion. As the major components of short-chain fatty acids (SCFAs), acetate potently inhibits autoreactive T cells, whereas butyrate promotes Treg activity. The combination of acetate and butyrate completely protect NOD mice from the development of the disease. This effect of acetate and butyrate may be therapeutically harnessed in the prevention and treatment of T1D and other autoimmune diseases in human. 17 For example, the vitamin A metabolite retinoic acid (RA) inhibits the differentiation of proinflammatory Th17 cells induced by IL-6 and promotes the differentiation of immunosuppressive Tregs. 18 Thus, it would be interesting to test whether dietary vitamin A derivatives and SCFAs have synergistic effects in the inhibition of T1D.
Collectively, this study identified novel mechanisms of the protective effect of acetate and butyrate on diabetes in NOD mice (summarized in Figure 1 ). Their data provide convincing experimental evidence that the dietary approach may represent a simple and highly effective strategy to prevent or treat autoimmune diabetes. If the result of this NOD mouse study can be extrapolated to human T1D patients, it may help in the design and development of acetate-and butyrateyielding medicinal food that will revolutionize the management of T1D.
